Johnson & Johnson Partners with Myeloma Ireland for ‘Rooted in Resilience’ garden at Bloom 2026
Johnson & Johnson has partnered with Myeloma Ireland as lead sponsor of the gold medal-winning ‘Rooted in Resilience’ garden at Bloom 2026.
Read more
multiple myeloma
DARZALEX® Becomes First Oncology Injectable Approved for Self-Administration in Europe
Johnson & Johnson has announced European approval for eligible multiple myeloma patients or caregivers to self-administer DARZALEX® from the fifth dose onwards.
Read more